Convano Inc. resolved to issue 250,000 stock acquisition rights (新株予約権) to 58 directors and employees of the company and its subsidiaries. The rights have an issue price of ¥10 per unit, with each unit conferring the right to acquire 100 common shares at an exercise price of ¥124 per share, exercisable between July 1, 2032 and March 9, 2036, subject to performance conditions regarding adjusted operating profit and revenue targets through fiscal year 2032.
¥3.1bn
›
Summary
Convano Inc. resolved to issue 250,000 stock acquisition rights (新株予約権) to 58 directors and employees of the company and its subsidiaries. The rights have an issue price of ¥10 per unit, with each unit conferring the right to acquire 100 common shares at an exercise price of ¥124 per share, exercisable between July 1, 2032 and March 9, 2036, subject to performance conditions regarding adjusted operating profit and revenue targets through fiscal year 2032.
Counterparty: Company directors and employees (58 individuals); subsidiary companies Convano Consulting, Shinx Healthcare, and DataStrategy